| Primary information |
|---|
| sequence ID | Seq_561 |
| Peptide sequence | ALREVQPVELPNCN |
| CancerPDF_ID | CancerPDF_ID8701, |
| PMID | 24694173 |
| Protein Name | Serum paraoxonase/arylesterase 1 |
| UniprotKB Entry Name | PON1_HUMAN |
| Fluid | Ascites fluid |
| Charge | 1 |
| Profiling Technique | LTQ-Orbitrap XL |
| Peptide Identification technique | X tandem for peptide identification |
| Labelled/Label Free | Label Free |
| CancerPDF_ID | CancerPDF_ID8701, |
| p-Value | NA |
| Software | "X tandem for peptide identification,Scaffold 2 software for any modification analysis" |
| Length | 14 |
| Cancer Type | Ovarian cancer |
| Database | IPI00218732 |
| Modification | NA |
| Number of Patients | 3 ovarian cancer patient and 3 non cancerous control |
| Regulation | Uniquely expressed in ovarian cancer patient |
| Validation | NA |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| Peptide Atlas | NA |
| IEDB | NA |